BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1974154)

  • 1. Increased blood clearance rate of indium-111 oxine-labeled autologous CD4+ blood cells in untreated patients with Hodgkin's disease.
    Grimfors G; Holm G; Mellstedt H; Schnell PO; Tullgren O; Björkholm M
    Blood; 1990 Aug; 76(3):583-9. PubMed ID: 1974154
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour imaging of indium-111 oxine-labelled autologous lymphocytes as a staging method in Hodgkin's disease.
    Grimfors G; Schnell PO; Holm G; Johansson B; Mellstedt H; Pihlstedt P; Björkholm M
    Eur J Haematol; 1989 Mar; 42(3):276-83. PubMed ID: 2494057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High numbers of CD4+ T cells showing abnormal recognition of DR antigens in lymphoid organs involved by Hodgkin's disease.
    Maggi E; Parronchi P; Macchia D; Bellesi G; Romagnani S
    Blood; 1988 May; 71(5):1503-6. PubMed ID: 2965930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Displacement of T lymphocytes with the 'Helper/Inducer' phenotype from peripheral blood to lymphoid organs in untreated patients with Hodgkin's disease.
    Romagnani S; Del Prete GF; Maggi E; Bosi A; Bernardi F; Ponticelli P; Di Lollo S; Ricci M
    Scand J Haematol; 1983 Oct; 31(4):305-14. PubMed ID: 6226085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of in vivo natural antitumor resistance and lymphocyte. Migration in mice: comparison of 125I-iododeoxyuridine with 111indium-oxine and 51chromium as cell labels.
    Wiltrout RH; Gorelik E; Brunda MJ; Holden HT; Herberman RB
    Cancer Immunol Immunother; 1983; 14(3):172-9. PubMed ID: 6404550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo tracing of indium-111 oxine-labeled human peripheral blood mononuclear cells in patients with lymphatic malignancies.
    Müller C; Zielinski CC; Linkesch W; Ludwig H; Sinzinger H
    J Nucl Med; 1989 Jun; 30(6):1005-11. PubMed ID: 2500501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Organ distribution of 111In-oxine labeled lymphocytes in normal subjects and in patients with chronic lymphocytic leukemia and malignant lymphoma].
    Matsuda S; Uchida T; Yui T; Kariyone S
    Kaku Igaku; 1982 Dec; 19(10):1497-510. PubMed ID: 6820400
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo traffic of indium-111-oxine labeled human lymphocytes collected by automated apheresis.
    Read EJ; Keenan AM; Carter CS; Yolles PS; Davey RJ
    J Nucl Med; 1990 Jun; 31(6):999-1006. PubMed ID: 2112185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell subsets in peripheral blood of patients with newly diagnosed and posttreatment Hodgkin's and non-Hodgkin's lymphomas. Analysis by monoclonal antibody staining and flow cytometry.
    De Angelis P; Kimmel M; Lacher M; Filippa D; Melamed MR
    Anal Quant Cytol Histol; 1988 Aug; 10(4):235-42. PubMed ID: 2971365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human scanning with In-111 oxine labeled autologous lymphocytes.
    Milgram R; Goodwin DA
    Clin Nucl Med; 1985 Jan; 10(1):30-4. PubMed ID: 3919985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 114Inm oxine-labelled lymphocytes--therapeutic applications.
    Hamilton D; Cowan RA; Drayson M; Sharma H; Cummins PE; Nuttall PM; Deakin D; Wagstaff J; Crowther D
    Nucl Med Commun; 1988 Oct; 9(10):797-802. PubMed ID: 3145475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease.
    Poppema S
    Am J Pathol; 1989 Aug; 135(2):351-7. PubMed ID: 2675617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indium-111 oxine labeled erythrocytes: cellular distribution and efflux kinetics of the label.
    Kurantsin-Mills J; Jacobs HM; Siegel R; Cassidy MM; Lessin LS
    Int J Rad Appl Instrum B; 1989; 16(8):821-7. PubMed ID: 2516078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absent splenic uptake of indium-111-oxine-labeled autologous leukocytes in functional asplenia.
    Hicks RJ; Young W; Shapiro B; Kuhl DE
    J Nucl Med; 1991 Mar; 32(3):524-6. PubMed ID: 1900887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease.
    Borowitz MJ; Croker BP; Metzgar RS
    Cancer Treat Rep; 1982 Apr; 66(4):667-74. PubMed ID: 6210433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8+ suppressor cells inhibit staphylococcal protein A-induced gamma interferon production by CD4+ lymphocytes.
    Kasparian SS; Menezes J
    Immunol Lett; 1991 Jan; 27(1):31-7. PubMed ID: 1673445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD).
    Jacob MC; Favre M; Lemarc'Hadour F; Sotto MF; Bonnefoix T; Sotto JJ; Bensa JC
    Am J Hematol; 1992 Jan; 39(1):45-51. PubMed ID: 1531569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of unlabeled indium oxine and indium tropolone on the function of isolated human lymphocytes.
    Signore A; Sensi M; Pozzilli C; Negri M; Lenzi GL; Pozzilli P
    J Nucl Med; 1985 Jun; 26(6):612-5. PubMed ID: 3158727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of leukocytes labeled with indium-111-2-mercaptopyridine-N-oxide and indium-111 oxine for abscess detection.
    Intenzo CM; Desai AG; Thakur ML; Park CH
    J Nucl Med; 1987 Apr; 28(4):438-41. PubMed ID: 3106593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
    Matchett KM; Huang AT; Kremer WB
    J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.